110 related articles for article (PubMed ID: 38754340)
1. Increased plasminogen activator inhibitor-1 (PAI-1) and its associations with metabolic risk in healthy young adults with early life stress.
Kudinova AY; Kulak MJ; Daniels TE; Angeles WLL; de la Monte S; Mathis KJ; Beck QM; Laumann LE; Tyrka AR
Psychoneuroendocrinology; 2024 Aug; 166():107071. PubMed ID: 38754340
[TBL] [Abstract][Full Text] [Related]
2. Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects.
Al-Hamodi Z; Ismail IS; Saif-Ali R; Ahmed KA; Muniandy S
Cardiovasc Diabetol; 2011 Mar; 10():23. PubMed ID: 21414238
[TBL] [Abstract][Full Text] [Related]
3. Associations of early life stress with leptin and ghrelin in healthy young adults.
Daniels TE; Mathis KJ; Gobin AP; Lewis-de Los Angeles WW; Smith EM; Chanthrakumar P; de la Monte S; Tyrka AR
Psychoneuroendocrinology; 2023 Mar; 149():106007. PubMed ID: 36577337
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen Activator Inhibitor-1 and Diagnosis of the Metabolic Syndrome in a West African Population.
Kodaman N; Aldrich MC; Sobota R; Asselbergs FW; Brown NJ; Moore JH; Williams SM
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27697752
[TBL] [Abstract][Full Text] [Related]
5. Increased Cardiometabolic Risk in Healthy Young Adults With Early Life Stress.
Kulak MJ; Los Angeles WL; Daniels TE; Mathis KJ; Gobin AP; Laumann LE; Beck Q; Tyrka AR
Psychosom Med; 2024 Feb-Mar 01; 86(2):72-82. PubMed ID: 38153259
[TBL] [Abstract][Full Text] [Related]
6. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
Gürlek A; Bayraktar M; Kirazli S
Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
[TBL] [Abstract][Full Text] [Related]
7. Association of prothrombotic adipokine (plasminogen activator inhibitor-1) with TSH in metabolic syndrome: a case control study.
Ahirwar AK; Singh A; Jain A; Kaim K; Bhardwaj S; Patra SK; Goswami B; Bhatnagar MK; Bhattacharjee J
Horm Mol Biol Clin Investig; 2017 Dec; 34(1):. PubMed ID: 29261514
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor type-1 is an independent marker of metabolic disorders in young adults born small for gestational age.
Meas T; Deghmoun S; Chevenne D; Gaborit B; Alessi MC; Lévy-Marchal C
J Thromb Haemost; 2010 Dec; 8(12):2608-13. PubMed ID: 20735726
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen Activator Inhibitor-1 and Adiponectin Are Associated With Metabolic Syndrome Components.
Vecchiola A; García K; González-Gómez LM; Tapia-Castillo A; Artigas R; Baudrand R; Kalergis AM; Carvajal CA; Fardella CE
Am J Hypertens; 2022 Apr; 35(4):311-318. PubMed ID: 34525175
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of plasminogen activator inhibitor-1 are associated with metabolic syndrome rather than with menopause.
Basurto L; Díaz A; Rodriguez A; Robledo A; Vega S; Garcia-Vega J; Martínez-Murillo C
Gynecol Endocrinol; 2019 Oct; 35(10):909-912. PubMed ID: 31023101
[TBL] [Abstract][Full Text] [Related]
11. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
Appel SJ; Harrell JS; Davenport ML
J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Power of Circulatory Metabolic Biomarkers as Metabolic Syndrome Risk Predictors in Community-Dwelling Older Adults in Northwest of England (A Feasibility Study).
Hassannejad R; Sharrouf H; Haghighatdoost F; Kirk B; Amirabdollahian F
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34209146
[TBL] [Abstract][Full Text] [Related]
14. Association of Metabolic Syndrome with Serum Adipokines in Community-Living Elderly Japanese Women: Independent Association with Plasminogen Activator-Inhibitor-1.
Takeuchi M; Tsuboi A; Kurata M; Fukuo K; Kazumi T
Metab Syndr Relat Disord; 2015 Nov; 13(9):415-21. PubMed ID: 26451494
[TBL] [Abstract][Full Text] [Related]
15. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
16. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
[TBL] [Abstract][Full Text] [Related]
17. Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity.
Mantovani RM; Rios DR; Moura LC; Oliveira JM; Carvalho FF; Cunha SB; Viana Mde F; Lamounier JA; Castro JC; Dusse LM; Simões e Silva AC
J Pediatr Endocrinol Metab; 2011; 24(5-6):361-7. PubMed ID: 21823537
[TBL] [Abstract][Full Text] [Related]
18. Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis.
Teixeira GG; Mari NL; de Paula JCC; Cataldi de Alcantara C; Flauzino T; Lozovoy MAB; Martin LMM; Reiche EMV; Maes M; Dichi I; Simão ANC
Clin Exp Med; 2020 Feb; 20(1):39-48. PubMed ID: 31758356
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 (PAI-1) in children and adolescents with type 1 diabetes mellitus: relation to diabetic micro-vascular complications and carotid intima media thickness.
Adly AA; Elbarbary NS; Ismail EA; Hassan SR
J Diabetes Complications; 2014; 28(3):340-7. PubMed ID: 24581943
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
Akanji AO; Abdullah A; Tahzeeb S
Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
